Background
Introduction
Study setting
Conceptual framework
Steps on the causal pathway/mediators | Indicators for measurement (data source) |
---|---|
Strengthened supervision | - Health workers received a supervision visit in the last 90 days (health worker survey) |
Active governing committees | - Health facility with a governing committee (health facility survey) - Health facility governing committees meetings held in last 90 days (health facility survey and health worker survey) - Minutes of health facility government committee meetings available (health facility survey and health worker survey) - Health workers satisfied with relationships between health facility and local leaders (health worker survey) |
Availability of drugs, medical supplies and equipment | - Index of stock out of 24 essential drugs in the past 90 days (health facility survey) - Index of stock out of 5 drugs used during delivery in the past 90 days (health facility survey) - Index of stock out of medical supplies in the past 90 days (health facility survey) - Index of stock out of SP (IPTp) (health facility survey) - Index of medical equipment functionality (health facility survey) |
Health worker more motivated and knowledgeable | - Intrinsic and extrinsic motivation score (health worker survey) |
Improved patient provider interactions | - Kindness during delivery ranked by women on a scale of 1–10 where 1 is minimum and 10 is maximum (women survey) |
Adherence to clinical protocol | - Uptake of IPT 2 during ANC (women survey) |
Increased outreach activities | - Frequency of outreach visits performed by health facility staff in past 90 days (health facility survey and health worker survey) - Outreach visits conducted by health facility staff in the last 90 days (health facility survey and health worker survey) |
Increase insurance enrolment | - Health insurance scheme available in the community (health facility survey) - Number of community health insurance scheme members per health facility (health facility survey) |
Reduction in user charges | - Probability of payment at delivery at the health facility (or public health facility) (women survey) |
Methods
Data sources
Data analysis
Step1: Estimating the impact of P4P on outcomes
Step 2: Identifying mediators
Step 3: Identifying direct and indirect causal effects
Step 4: Sensitivity analysis
Results
Descriptive statistics
Baseline | Endline | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intervention | Control | Total | Difference intervention control | Intervention | Control | Total | Difference intervention control | |||||||
N
| Mean (SE) |
N
| Mean (SE) |
N
| Mean (SE) |
T test (P value) |
N
| Mean (SE) |
N
| Mean (SE) |
N
| Mean (SE) |
T Test (P value) | |
Outcome | ||||||||||||||
Facility-based delivery | 1389 | 84.7 (36.0) | 1485 | 86.8 (33.9) | 2874 | 85.8 (34.9) | −2.1 (0.113) | 1449 | 89.2 (31.0) | 1462 | 83.1 (37.5) | 2911 | 86.2 (34.5) | 6.1 (0.000) |
Public facility delivery | 1389 | 76.7 (42.3) | 1485 | 77.8 (41.6) | 2874 | 77.3 (41.9) | −1.0 | 1449 | 81.6 (38.8) | 1462 | 77.1 (42.0) | 2911 | 79.3 (40.5) | 4.5 (0.003) |
Taken at least 2 doses of anti-malaria drug during pregnancy | 1038 | 49.5 (50.0) | 1212 | 56.7 (49.6) | 2250 | 53.4 (49.9) | −7.2 (0.001) | 1279 | 72.9 (44.4) | 1252 | 69.2 (46.2) | 2531 | 71.1 (45.3) | 3.8 (0.036) |
Potential mediators | ||||||||||||||
Health workers received supervision visit in the last 90 days (%) | 1315 | 88.7 (31.6) | 1489 | 90.8 (28.9) | 2804 | 89.8 (30.2) | −2.1 (0.073) | 1165 | 98.5 (12.3) | 1172 | 84.7 (36.0) | 2337 | 91.6 (27.8) | 13.7 (0.000) |
Health facility with a governing committee (%) | 1202 | 74.3 (23.0) | 1384 | 70.5 (45.6) | 2586 | 72.2 (44.8) | 3.8 (0.029) | 1119 | 80.6 (39.5) | 1442 | 74.7 (43.5) | 2891 | 77.7 (41.7) | 5.9 (0.000) |
Governing committee met in the past 90 days (%) | 1345 | 94.4 (23.0) | 1444 | 93.0 (25.5) | 2789 | 93.7 (24.3) | 1.4 (0.124) | 1395 | 63.4 (48.2) | 1442 | 44.5 (49.7) | 2837 | 53.8 (49.9) | 19.0 (0.000) |
Minutes of health facilities governing committee meetings available (%) | 1249 | 92.7 (26.0) | 1300 | 80.5 (39.7) | 2549 | 86.5 (34.2) | 12.3 (0.000) | 1193 | 90.1 (29.9) | 1077 | 92.9 (25.6) | 2270 | 91.5 (28.0) | −2.8 (0.016) |
Health worker satisfied with relationship with local leaders (%) | 1374 | 63.2 (48.3) | 1489 | 58.2 (49.3) | 2863 | 60.6 (48.9) | 4.9 (0.000) | 1430 | 63.1 (48.3) | 1462 | 57.1 (49.5) | 2892 | 60.1 (49.0) | 6.0 (0.001) |
Drug stock-out index-general (0–1 index) (%) | 1323 | 54.6 (23.3) | 1468 | 45.7 (27.8) | 2791 | 49.9 (26.2) | 8.9 (0.000) | 1449 | 37.6 (25.3) | 1462 | 45.7 (29.7) | 2911 | 41.7 (27.8) | −8.0 (0.000) |
Drugs at delivery-stock-out index (0–1 index) (%) | 1323 | 54.3 (31.1) | 1448 | 38.6 (34.4) | 2771 | 46.1 (33.8) | 15.7 (0.000) | 1449 | 36.7 (32.6) | 1462 | 48.8 (37.9) | 2911 | 42.8 (35.9) | −12.1 (0.000) |
Oxytocin injection stock-out last 90 days (%) | 1302 | 42.0 (49.4) | 1448 | 17.3 (37.9) | 2750 | 29.0 (45.4) | 24.7 (0.000) | 1449 | 22.3 (41.6) | 1462 | 33.7 (47.3) | 2911 | 28.0 (44.9) | −11.4 (0.000) |
Ergometrin injection stock-out last 90 days (%) | 1286 | 65.4 (47.6) | 1408 | 51.3 (50.0) | 2694 | 58.1 (49.4) | 14 (0.000) | 1449 | 42.9 (49.5) | 1462 | 57.1 (49.5) | 2911 | 50.1 (50.0) | −14.2 (0.000) |
Misoprostol tablet stock-out last 90 days (%) | 1302 | 58.8 (49.2) | 1428 | 49.1 (50.0) | 2730 | 53.7 (49.9) | 9.7 (0.000) | 1449 | 44.8 (49.7) | 1462 | 55.7 (49.7) | 2911 | 50.3 (50.0) | −10.9 (0.000) |
Medical supplies stock-out index (0–1 index) (%) | 1180 | 39.3 (25.3) | 1227 | 25.6 (23.2) | 2407 | 32.3 (25.2) | 13.8 (0.000) | 1449 | 20.0 (19.1) | 1462 | 21.3 (18.4) | 2911 | 20.6 (18.8) | −1.3 (0.060) |
Index of stock out of IPTp last 90 days (%) | 1302 | 27.3 (44.6) | 1486 | 19.5 (39.5) | 2770 | 23.1 (42.1) | 7.9 (0.000) | 1449 | 6.8 (25.1) | 1462 | 10.9 (31.2) | 2911 | 8.9 (28.4) | −4.2 (0.000) |
Service delivery disrupted due to broken equipment last 90 days (%) | 1323 | 24.8 (43.2) | 1468 | 12.5 (33.0) | 2791 | 18.3 (38.7) | 12.3 (0.000) | 1392 | 5.2 (22.2) | 1462 | 6.4 (24.4) | 2854 | 5.8 (23.3) | −1.2 (0.174) |
Intrinsic motivation score | 1374 | −7.7 (95.7) | 1489 | 7.7 (74.1) | 2863 | 0.3 (85.4) | −15.4 (0.000) | 1429 | −7.2 (93.2) | 1462 | 8.05 (73.7) | 2891 | 0.5 (84.3) | −15.3 (0.000) |
Extrinsic motivation score | 1374 | −13.7 (68.2) | 1489 | 1.1 (82.0) | 2863 | −6.0 (76.1) | −14.8 (0.000) | 1430 | −12.0 (68.5) | 1462 | 0.5 (80.4) | 2892 | −5.7 (75.0) | −12.6 (0.000) |
Health worker knowledge (%) a
| 1299 | 47.0 (27.4) | 1467 | 67.7 (23.2) | 2766 | 57.9 (27.0) | −20.0 (0.000) | 1388 | 57.7 (9.8) | 1347 | 59.6 (8.7) | 2735 | 58.6 (9.3) | −19 (0.000) |
Kindness at delivery (%) a,b
| 1389 | 74.8 (10.9) | 1485 | 79.0 (10.1) | 2874 | 77.0 (10.7) | −4.2 (0.000) | 1449 | 88.9 (9.1) | 1452 | 83.7 (11.7) | 2911 | 83.8 (10.5) | 0.21 (0.590) |
Outreach visits conducted by health facility staff in the last 90 days (%) | 1358 | 60.6 (48.9) | 1424 | 58.5 (49.3) | 2782 | 59.5 (49.1) | 2.1 (0.258) | 1449 | 73.5 (44.1) | 1462 | 60.0 (49.0) | 2911 | 66.7 (47.1) | 13.4 (0.000) |
Frequency of outreach visits performed by staff in last 90 days | 1358 | 2.0 (2.8) | 1424 | 2.0 (2.2) | 2782 | 2.1 (2.5) | −0.0 (0.843) | 1449 | 2.5 (3.27) | 1462 | 2.03 (3.0) | 2911 | 2.3 (3.1) | 0.48 (0.000) |
Health insurance scheme available in the community (%) | 1358 | 79.8 (40.1) | 1429 | 55.9 (49.7) | 2787 | 67.5 (46.8) | 24.0 (0.000) | 1449 | 84.0 (36.7) | 1462 | 62.4 (48.4) | 2911 | 73.2 (44.3) | 21.5 (0.000) |
Number of community health insurance scheme members per HF | 991 | 23.3 (40.9) | 1144 | 14.8 (31.9) | 2135 | 18.8 (36.6) | 8.5 (0.000) | 1369 | 36.9 (52.9) | 1424 | 32.5 (56.2) | 2793 | 34.7 (54.6) | 4.3 (0.038) |
Percentage of women who paid for delivery in a HF (%)b
| 1389 | 19.9 (20.0) | 1485 | 14.3 (23.8) | 2874 | 17.0 (22.2) | 5.5 (0.000) | 1449 | 0.133 (0.205) | 1.462 | 0.119 (0.222) | 2911 | 0.126 (0.214) | 0.014 (0.082) |
Mediation analysis
Effect of P4P (% change) | Observations | |
---|---|---|
Maternal care outcomes | ||
Facility-based delivery | 8.2*** (3.6; 12.8) | 5747 |
Public facility delivery | 6.5** (1.3; 11.7) | 5747 |
Taken at least 2 doses of anti-malaria drug | 10.3*** (4.4; 16.1) | 4759 |
Potential mediators | ||
Health workers received supervision visit in the last 90 days | 18.0** (4.0; 32.0) | 5100 |
Drug stock-out index-general (0–1 index) | −17.2***BS
(−28.6;−5.8) | 5659 |
Drugs at delivery stock-out index (0–1 index) | −27.0***BS
(−43.4;−10.6) | 5639 |
Oxytocin injection stock-out last 90 days | −36.2***BS
(−55.9;−16.4) | 5618 |
Ergomentrin injection stock-out last 90 days | −26.1** (−48.2;−4.0) | 5562 |
Medical supplies stock-out index (0–1 index) | −14.8***BS
(−24.8;−4.9) | 5278 |
Service delivery disrupted due to broken equipment last 90 days | −14.9** (−29.3;−0.4) | 5602 |
Health worker knowledge | 18.8***BS
(10.4; 27.2) | 5461 |
Kindness ranks for health workers at delivery | 4.3* (−0.4; 9.0) | 5747 |
Percentage of women who paid for delivery in a HF | −4.5* (−9.5; 0.6) | 5750 |
Facility-based delivery (% change) | Public facility delivery (% change) | Taken at least 2 doses of anti-malaria drug (% change) | |
---|---|---|---|
Effect of P4P without mediators
| 8.2*** (3.6; 12.8) | 6.5** (1.3; 11.7) | 10.3*** (4.4; 16.1) |
Effect of P4P mediated by
| |||
Health worker received supervision in the last 90 days
| |||
- Coefficient on P4P (B
1
)
| 5.6** (4.0; 10.7) | 4.3 (−1.5; 10.2) | 10.7*** (4.1; 17.3) |
- Coefficient on mediator (B
4
)
| 3.1 (-2.3; 8.5) | 0.8 (-6.6; 8.2) | 8.5*** (2.4; 14.6) |
Drug stock-out index-general (0-1 index) | |||
- Coefficient on P4P (B1) | 7.8*** (3.0; 12.6) | 5.5** (0.2; 10.9 | 11.5*** (5.5; 17.4) |
- Coefficient on mediator (B4) | −3.6 (−9.2; 1.9) | −2.9 (−9.0; 3.2) | 7.0 (−1.8; 15.8) |
Drugs at delivery -stock-out index (0–1 index) | |||
- Coefficient on P4P (B1) | 7.4*** (2.5; 12.3) | 4.6* (−0.6; 9.9) | 10.6*** (4.6; 16.5) |
- Coefficient on mediator (B4) | −3.2 (−7.6; 1.2) | −4.3* (−9.0; 0.3) | 0.8 (−5.6; 7.2) |
Oxytocin injection stock-out last 90 days
| |||
- Coefficient on P4P (B
1
)
| 6.3*** (1.5; 11.1) | 3.8 (−1.6; 9.1) | 10.7*** (4.6; 16.9) |
- Coefficient on mediator (B
4
)
| −4.9*** (−8.4;−1.4) | −5.3*** (−8.9;−1.7) | 0.9 (−4.2; 6.1) |
Ergometrin injection stock-out last 90 days | |||
- Coefficient on P4P (B1) | 8.1*** (2.8; 13.4) | 5.7** (0.1; 11.4) | 10.8*** (4.7; 16.8) |
- Coefficient on mediator (B4) | 1.0 (−3.7; 5.6) | 0.5 (−4.4; 5.5) | 0.7 (−4.0; 5.4) |
Medical supplies stock-out index (0–1 index) | |||
- Coefficient on P4P (B1) | 8.0*** (3.1; 12.9) | 4.9* (−0.8; 10.6) | 10.9*** (4.3; 17.5) |
- Coefficient on mediator (B4) | −6.8 (−16.5; 2.8) | −8.0 (−18.2; 2.2) | 1.3 (−9.8; 12.4) |
Service delivery disrupted due to broken equipment last 90 days | |||
- Coefficient on P4P (B1) | 7.7*** (3.0; 12.4) | 5.4** (0.1; 10.6) | 9.9*** (3.8; 16.0) |
- Coefficient on mediator (B4) | −3.7 (−8.8; 1.5) | −3.7 (−10.3; 2.9) | −0.5 (−8.8; 7.7) |
Health worker knowledge | |||
- Coefficient on P4P (B1) | 8.6*** (4.0; 13.2) | 6.6** (1.5; 11.7;) | 11.2*** (4.7; 17.6) |
- Coefficient on mediator (B4) | −5.6 (−14.5; 3.2) | −1.7 (−12.0; 8.7) | −3.4 (−17.1; 10.3) |
Health worker kindness at delivery
| |||
- Coefficient on P4P (B
1
)
| 4.3 (−2.2; 10.8) | 3.3 (−3.2; 9.9) | 10.0*** (4.0; 15.9) |
- Coefficient on mediator (B
4
)
| 9.1*** (6.4; 11.8) | 8.0*** (4.7; 10.3) | 0.3 (−1.9; 26) |
Percentage of women who paid for delivery in a HF
| |||
- Coefficient on P4P (B
1
)
| 4.0 (−2.5; 10.5) | 1.5 (−5.0; 8.0) | 9.4*** (3.5; 15.3) |
- Coefficient on mediator (B
4
)
| −93.5*** (−122.7;−64.4) | −112.9*** (−141.0;−84.8) | −17.9* (−35.8; 0.1) |
Taken at least 2 doses of anti-malaria drug during pregnancy | |||
- Coefficient on P4P (B1) | 9.3*** (2.5) | 8.2*** (2.9) | |
- Coefficient on mediator (B4) | 1.4 (1.2) | 2.1* (1.2) |
Facility based delivery (% change) | Public facility delivery (% change) | Taken at least 2 doses of anti-malaria drug (% change) | |
---|---|---|---|
P4P | |||
Total effect | 8.2*** | 6.5*** | 10.3*** |
Standard error | (3.6; 12.8) | (1.3; 11.7) | (4.4; 16.1) |
Indirect effect of P4P on outcome through mediators | |||
Health worker received supervision in last 90 days | |||
Indirect effect (coefficient interaction) | 1.5*** | ||
Confidence Interval | (0.1, 3.0) | ||
Percentage of total effect explained | 15 | ||
Correlation at which ACME = 0 | −0.0343 | ||
Oxytocin injection stock-out | |||
Indirect effect (coefficient interaction) | 1.8*** | 1.9*** | |
Confidence Interval | (0.7, 2.9) | (0.8, 3.1) | |
Percentage of total effect explained | 22 | 30 | |
Correlation at which ACME = 0 | −0.0439 | −0.0437 | |
Average kindness (excluding woman herself) | |||
Indirect effect (coefficient interaction) | 3.9*** | 3.2*** | |
Confidence interval | (3.0, 4.7) | (2.4, 3.9) | |
Percentage of total effect explained | 48 | 49 | |
Correlation at which ACME = 0 | 0.2085 | −0.0202 | |
Mean of women who paid for delivery (excluding woman herself) | |||
Indirect effect (coefficient interaction) | 3.9*** | 5.0*** | |
Confidence interval | (3.0, 4.8) | (3.9, 6.3) | |
Percentage of total effect explained | 48 | 78 | |
Correlation at which ACME = 0 | −0.2326 | −0.2590 |